Keep an Eye on These 4 Stocks Today 👀

[Image](www.elitetrade.club) Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Happy Friday! It's March 17th. Happy Saint Patrick's Day! 🍀 I hope you have a great weekend. Now, let's get ready to trade! Markets 📈 The Nasdaq rallied 2.4% on Thursday as investors reacted to news that Wall Street was planning to come the regional banking sector's rescue. The Dow added 1.1%, and the S&P 500 jumped 1.7%, while the small-cap Russell 2K added 1.7%. Futures are looking shaky in early morning trading. S&P 500 contracts are currently showing a 0.1% loss. Sponsored [Five Growth Stocks to Watch Closely...]( One of these 5 stocks has produced 18 positive returns for its shareholders over the past two decades alone. Another is experiencing a current supply-demand imbalance in the market which has contributed to high prices - which is great for investors... [Click Here to See All 5 Stocks.]( Premarket Highlights 🔎 💰 Wall Street Banks Rescue First Republic Eleven banks have deposited a combined total of $30 billion with First Republic Bank [FRC] in an effort a shore up the bank's liquidity against a spreading banking in the regional banking sector. Sources say Treasury Sect. Janet Yellen and other Washington officials worked closely with the banks involved in the rescue. What to Watch Today 👀 Bank Stocks The banking crisis is at the forefront of most investors' minds heading into today's session. It's been a choppy week of up-and-down trading action in the market, and we could see more of that in today's session. Wall Street's bid to rescue First Republic gave the market some relief, but there are other banks facing troubles as well. Regional bank stocks could prove to be a reliable gauge for investor sentiment today and next week. Major Earnings 💰 Xpeng Inc. Dr [XPEV] ... AM Waterdrop Inc. Dr [WDH] ... AM Tuniu Corporation Dr [TOUR] ... AM Gigacloud Technology Inc [GCT] ... AM Dynagas Lng Partners Lp [DLNG] ... AM Nortech Systems Incorporated [NSYS] ... AM Economy 🏗 - Industrial production [Feb] ... 9:15a - Capacity utilization [Feb] ... 9:15a - U.S. leading economic index [Feb] ... 10:00a - Consumer sentiment [Mar] ... 10:00a Running Hot 🔥 Gainers - System1 [SST] >> +30.5% - PaxMedica [PXMD] >> +24.1% - Biomea Fusion [BMEA] >> +15.4% Decliners - Credit Suisse ADR [CS] >> (7.3%) - Sarepta [SRPT] >> (17.8%) - Diebold [DBD] >> (23.4%) FedEx [FDX] - Last Close: $204.05 FedEx is rallying on the heels of a strong earnings report. The shipping giant released its fiscal Q3 results after Thursday's close, and the market was very impressed with what it saw. FedEx's fiscal Q3 EPS of $3.41 beat the Street's $2.73 per share estimate, but revenues of $22.2 billion fell short of Wall Street's target. However, the company said it's making progress in its efforts to shave $3.7 billion in costs from its global delivery business and hiked its full-year guidance. FDX is this morning's top S&P 500 stock with an 11.6% gain. My Take: FDX appears to be on the right track, but an economic slowdown can be a major headwind for shipping companies. Sentiment appears to be behind the stock for now, but I would be wary of a long-term investment at this time. Enzo Biochem [ENZ] - Last Close: $1.19 Enzo Biochem just landed a huge deal to sell some key assets. The life sciences company announced on Thursday that it has agreed to sell its clinical lab assets to Laboratory Corp of America [LH]. Under the terms of the deal, Enzo Biochem will receive about $146 million in cash, according to a company press release. Completion of the sale is contingent on Enzo Biochem shareholders' approval, which the company plans to obtain at an upcoming special meeting. ENZ is today's top premarket performer with a 68.0% gain on active premarket trading volume. My Take: The market likes the deal, but ENZ's chart is ugly. This stock has had a rough 12 months, and I'm not sure if this news will give it the boost it needs to break out of its long-term funk. Histogen [HSTO] - Last Close: $0.8623 Histogen is pushing higher after a Thursday evening announcement. The clinical-stage therapeutics company was issued a U.S. patent that will cover its portfolio of anti-inflammatory caspase inhibitors, such as CTS-2090. Histogen was awarded Patent No. 11,579,703 titled, "“Caspase Inhibitors and Methods of Use Thereof,” from the US Patent & Trademark Office. This patent notes that Histogen's CTS-2090 has demonstrated potent oral activity in a well characterized model of ulcerative colitis. A Histogen spokesperson said the patent "builds upon Histogen’s growing proprietary caspase inhibitor portfolio," which includes another patent issued in September 2022. HSTO is one of this morning's top stocks with a 32.2% gain on active trading volume. My Take: If Histogen continues to acquire intellectual property at this rate, it could become a Big Pharma buyout target. This stock could be worth keeping an eye on in the weeks and months ahead. Hub Cyber Security [HUBC] - Last Close: $2.39 Hub Cyber is running hot in the wake of a recent announcement. Earlier this week, the cybersecurity company announced it had made a $4 million sale of its common stock to PIPE investors at a price of $10 per share. Shares of HUBC have been rallying since the announcement was made. Since Monday's close, shares are up 58%. Today, this stock is adding to its gains, despite no additional news to explain the push higher. HUBC is up 23.4% in today's premarket, and it's one of this morning's most active stocks. My Take: There has been a lot of activity in HUBC since it made its market debut earlier in the month. This stock could have long-term growth potential, as it seems to have Wall Street behind it. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 to sign up now and get our watchlists sent directly to your phone! Or text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](